CA3197199A1 - Compounds and compositions for the treatment of cryptosporidiosis - Google Patents
Compounds and compositions for the treatment of cryptosporidiosisInfo
- Publication number
- CA3197199A1 CA3197199A1 CA3197199A CA3197199A CA3197199A1 CA 3197199 A1 CA3197199 A1 CA 3197199A1 CA 3197199 A CA3197199 A CA 3197199A CA 3197199 A CA3197199 A CA 3197199A CA 3197199 A1 CA3197199 A1 CA 3197199A1
- Authority
- CA
- Canada
- Prior art keywords
- methyl
- carboxamido
- pyridine
- methylpyrazolo
- chlorobenzoate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063091866P | 2020-10-14 | 2020-10-14 | |
| US63/091,866 | 2020-10-14 | ||
| PCT/IB2021/059376 WO2022079616A1 (en) | 2020-10-14 | 2021-10-12 | Compounds and compositions for the treatment of cryptosporidiosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3197199A1 true CA3197199A1 (en) | 2022-04-21 |
Family
ID=78302850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3197199A Pending CA3197199A1 (en) | 2020-10-14 | 2021-10-12 | Compounds and compositions for the treatment of cryptosporidiosis |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12018024B2 (https=) |
| EP (1) | EP4229055B1 (https=) |
| JP (1) | JP7791184B2 (https=) |
| CN (1) | CN116368137A (https=) |
| AR (1) | AR123766A1 (https=) |
| AU (1) | AU2021362803A1 (https=) |
| CA (1) | CA3197199A1 (https=) |
| MX (1) | MX2023004435A (https=) |
| PY (1) | PY2189412A (https=) |
| TW (1) | TW202229277A (https=) |
| UY (1) | UY39466A (https=) |
| WO (1) | WO2022079616A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR132352A1 (es) * | 2023-04-13 | 2025-06-18 | Syngenta Crop Protection Ag | Derivados de imidazo[1,2-a]pirazina |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2925757T (lt) | 2012-11-19 | 2017-12-27 | Novartis Ag | Junginiai ir kompozicijos, skirti parazitinių ligų gydymui |
| CN108495853A (zh) * | 2016-01-21 | 2018-09-04 | 诺华股份有限公司 | 用于治疗隐孢子虫病的化合物和组合物 |
| GB201700692D0 (en) | 2017-01-16 | 2017-03-01 | Salvensis | Novel compounds and their use in the treatment of schistosomiasis |
-
2021
- 2021-10-12 WO PCT/IB2021/059376 patent/WO2022079616A1/en not_active Ceased
- 2021-10-12 PY PY202102189412A patent/PY2189412A/es unknown
- 2021-10-12 AR ARP210102815A patent/AR123766A1/es unknown
- 2021-10-12 AU AU2021362803A patent/AU2021362803A1/en active Pending
- 2021-10-12 TW TW110137677A patent/TW202229277A/zh unknown
- 2021-10-12 CA CA3197199A patent/CA3197199A1/en active Pending
- 2021-10-12 JP JP2023522570A patent/JP7791184B2/ja active Active
- 2021-10-12 CN CN202180069247.7A patent/CN116368137A/zh active Pending
- 2021-10-12 EP EP21794994.0A patent/EP4229055B1/en active Active
- 2021-10-12 MX MX2023004435A patent/MX2023004435A/es unknown
- 2021-10-12 UY UY0001039466A patent/UY39466A/es unknown
- 2021-10-12 US US17/499,663 patent/US12018024B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AR123766A1 (es) | 2023-01-11 |
| MX2023004435A (es) | 2023-05-08 |
| UY39466A (es) | 2022-05-31 |
| TW202229277A (zh) | 2022-08-01 |
| CN116368137A (zh) | 2023-06-30 |
| WO2022079616A1 (en) | 2022-04-21 |
| US20220112189A1 (en) | 2022-04-14 |
| PY2189412A (es) | 2022-05-17 |
| US12018024B2 (en) | 2024-06-25 |
| JP2023545452A (ja) | 2023-10-30 |
| EP4229055A1 (en) | 2023-08-23 |
| EP4229055B1 (en) | 2026-03-04 |
| JP7791184B2 (ja) | 2025-12-23 |
| AU2021362803A1 (en) | 2023-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101746314B1 (ko) | Gabaa 수용체 조절제로서 이미다조피리다진 유도체 | |
| CN104725359B (zh) | 取代的哌嗪化合物及其使用方法和用途 | |
| TWI800696B (zh) | 7-(甲基胺基)吡唑并[1,5-a]嘧啶-3-甲醯胺衍生物 | |
| RS56720B1 (sr) | Jedinjenja i kompozicije za lečenje parazitskih oboljenja | |
| CN105473573B (zh) | 用作激酶抑制剂的咔唑甲酰胺化合物 | |
| CN102245604A (zh) | 抗病毒化合物 | |
| WO2022214691A1 (en) | Deuterated dhodh inhibitors | |
| CN106243088A (zh) | 取代的哌嗪化合物及其使用方法和用途 | |
| WO2017125898A1 (en) | Compounds and compositions for the treatment of cryptosporidiosis | |
| JP2019048813A (ja) | キナーゼ阻害活性を有するベンズヒドロール−ピラゾール誘導体及びその使用 | |
| US10316038B2 (en) | Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer | |
| KR20200041954A (ko) | 화합물, 이의 약제학적 조성물, 및 이의 용도 및 응용 | |
| KR102417483B1 (ko) | 융합된 아자헤테로사이클릭 화합물 및 ampa 수용체 조절제로서의 이들의 용도 | |
| EP4229055B1 (en) | Compounds and compositions for the treatment of cryptosporidiosis | |
| CN108299437B (zh) | 八氢吡咯并[3,4-c]吡咯衍生物及其用途 | |
| CN104725363A (zh) | 取代的哌嗪化合物及其使用方法和用途 | |
| WO2015193228A1 (de) | Bet-proteininhibitorische 1,4-dihydropyrido[3,4-b]pyrazinone mit para-substituierter aromatischer amino- oder ethergruppe | |
| HK40130359A (zh) | 犬janus激酶抑制剂及其用途 | |
| CA3250182A1 (en) | TRYPTANTHRINE DERIVATIVES AND THEIR USES | |
| TW202227447A (zh) | 嘧啶酮類化合物及其用途 | |
| NZ731946A (en) | Indole carboxamide compounds useful as kinase inhibitors | |
| NZ731946B2 (en) | Indole carboxamide compounds useful as kinase inhibitors | |
| HK1161529B (en) | Pyrazolopyrimidine jak inhibitor compounds and methods | |
| HK1161529A1 (en) | Pyrazolopyrimidine jak inhibitor compounds and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240930 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240930 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250916 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250916 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20251001 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20251001 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20251001 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20251203 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20251203 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20251203 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20251203 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20251203 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251209 |